Veteran venture investor and operator focused on early-stage technology and healthcare companies, D. Garet Strange brings board-level experience, portfolio construction skills and deal-sourcing networks across the US. Prior roles span startup leadership and venture investing, with a track record of guiding exits, governance and strategic scaling. Known for active engagement in seed-to-Series A rounds, capital allocation discipline and mentorship of founding teams, typically partnering with institutional co-investors.
Veteran venture investor and operator focused on early-stage technology and healthcare companies, D. Garet Strange brings board-level experience, portfolio construction skills and deal-sourcing networks across the US. Prior roles span startup leadership and venture investing, with a track record of guiding exits, governance and strategic scaling. Known for active engagement in seed-to-Series A rounds, capital allocation discipline and mentorship of founding teams, typically partnering with institutional co-investors.
Focuses on early-stage technology and healthcare investments, prioritizing seed to Series A opportunities where founder-market fit and defensible product differentiation are clear. Employs active, board-level stewardship to accelerate go-to-market, governance and follow-on fundraising, while co-investing with institutional partners to diversify risk. Capital allocation favors concentrated, stage-weighted commitments, rigorous due diligence, and milestone-driven follow-ons. Time horizon is growth-oriented multi-year exits; risk discipline emphasizes operational KPIs, capital efficiency and repeatable business models.
Focuses on early-stage technology and healthcare investments, prioritizing seed to Series A opportunities where founder-market fit and defensible product differentiation are clear. Employs active, board-level stewardship to accelerate go-to-market, governance and follow-on fundraising, while co-investing with institutional partners to diversify risk. Capital allocation favors concentrated, stage-weighted commitments, rigorous due diligence, and milestone-driven follow-ons. Time horizon is growth-oriented multi-year exits; risk discipline emphasizes operational KPIs, capital efficiency and repeatable business models.
| Trades 2242 | Longs Won 1487/2242 66% | Profit Factor 15.21 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $280,170.8 |
| Average Win $66,319.93 | Best Trade (Aug 17) $8.05M | Sharpe Ratio -77.95 |
| Average Loss -$8,585.9 | Worst Trade (Mar 31) -$349,354.47 | Z-Score 5.3 (100%) |
| Commissions $0 | Avg. Trade Length 11m 3w 5d | Expectancy $41,095.18 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 43,478 | 39,130 | 34,783 | 30,435 | 26,087 | 21,739 | 17,391 | 13,043 | 8,696 | 4,348 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 13,646 | $2.73M | $4.17M | - | $1.44M | 52.77% | +0.996% |
ABBV AbbVie Inc. | 1,609 | $267,477.3 | $400,254.82 | - | $132,777.52 | 49.64% | 0.0 |
AGG iShares Core U.S. Aggregate Bond ETF | 2,667 | $265,344.1 | $259,845.81 | - | -$5,498.29 | -2.07% | 0.0 |
AGGA Astoria Dynamic Core US Fixed Income ETF | 839,138 | $21.2M | $20.89M | - | -$309,223.32 | -1.46% | 0.0 |
ALLW SPDR Bridgewater All Weather Mutual Fund | 238,443 | $6.62M | $7.14M | - | $526,565.59 | 7.96% | 0.0 |
AMAT Applied Materials, Inc. | 972 | $180,686.36 | $519,572.88 | - | $338,886.52 | 187.56% | -2.483% |
AMP Ameriprise Financial, Inc. | 551 | $209,599.33 | $311,353.57 | - | $101,754.24 | 48.55% | 0.0 |
AMZN Amazon.com Inc | 9,502 | $1.78M | $2.54M | - | $762,249.42 | 42.88% | 0.0 |
AOA iShares Core Aggressive Allocation ETF | 12,267 | $1.1M | $1.22M | - | $121,737.94 | 11.08% | 0.0 |
ASML ASML Holding N.V. New York Registry Shares | 167 | $220,011 | $302,281.67 | - | $82,270.67 | 37.39% | 0.0 |
ATYR Atyr Pharma Inc. | 35,992 | $24,527.32 | $19,446.48 | - | -$5,080.84 | -20.72% | +0.056% |
AVGO Broadcom Inc. | 1,142 | $323,185.74 | $475,129.1 | - | $151,943.36 | 47.01% | 0.0 |
AXP American Express Company | 2,783 | $521,668.63 | $957,574.6 | - | $435,905.97 | 83.56% | 0.0 |
BAB Invesco Taxable Municipal Bond ETF | 196,857 | $5.28M | $5.2M | - | -$83,066.03 | -1.57% | 0.0 |
BAC Bank of America Corporation | 26,302 | $902,204.95 | $1.7M | - | $802,427.67 | 88.94% | 0.0 |
BBIB JPMorgan BetaBuilders U.S. Treasury Bond 3-10 Year ETF | 11,894 | $1.15M | $1.15M | - | $3,215.31 | 0.28% | 0.0 |
BKR Baker Hughes Company | 7,539 | $458,906.18 | $484,606.92 | - | $25,700.74 | 5.6% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 1,012 | $445,666.13 | $516,039.04 | - | $70,372.91 | 15.79% | -0.016% |
BSCQ Invesco BulletShares 2026 Corporate Bond ETF | 35,469 | $689,512.41 | $693,596.29 | - | $4,083.88 | 0.59% | 0.0 |
BSCR Invesco BulletShares 2027 Corporate Bond ETF | 18,912 | $368,455.89 | $371,526.24 | - | $3,070.35 | 0.83% | 0.0 |